ABX-196

N/A

Report date: 2022/11/13 11:44:43
NME

Base Information

Drug NameABX-196
Drug Alias NameABX-196PBS-96
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNatural killer cells stimulants
TargetsUpdating
Therapy Area/IndicationsCarcinoma, Hepatocellular
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAbivax Sa
China Registration ClassN/A

Develop Information

Active CompaniesAbivax Sa
Inactive CompaniesN/A
Active IndicationsCarcinoma, Hepatocellular
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A